Bruno Spire

High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients—authors' response

Vincent Calvez, Bruno Hoen, David Rey, 2009 .

Adherence to Antiretroviral Treatment in HIV-Positive Patients in the Cameroon Context: Promoting the Use of Medication Reminder Methods

Christian Laurent, E. Delaporte, B. Spire, 2011, Journal of acquired immune deficiency syndromes.

HIV experts on the decision to use early ART for prevention in France: are we there yet?

Bruno Spire, Jean-Pierre Routy, Bertrand Lebouché, 2012, Retrovirology.

International AIDS Society global scientific strategy: towards an HIV cure 2016

Richard Jefferys, David Margolis, Jintanat Ananworanich, 2016, Nature Medicine.

Drug use patterns and adherence to treatment among HIV-positive patients: evidence from a large sample of French outpatients (ANRS-EN12-VESPA 2003).

Patrick Peretti-Watel, F. Lert, B. Spire, 2006, Drug and alcohol dependence.

Finding a cure for HIV: will it ever be achievable?

Julian H Elliott, S. Lewin, B. Spire, 2011, Journal of the International AIDS Society.

On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.

David Thompson, Laurence Meyer, Jean-Pierre Aboulker, 2015, The New England journal of medicine.

Factors correlated with disclosure of HIV infection in the French Antilles and French Guiana: results from the ANRS-EN13-VESPA-DFA Study

F. Lert, B. Spire, A. Schmaus, 2007, AIDS.

Withdrawal symptoms as a predictor of mortality in patients HIV-infected through drug use and receiving highly active antiretroviral therapy (HAART).

Roch Giorgi, Camelia Protopopescu, M. Carrieri, 2009, Drug and alcohol dependence.